Strides Pharma Science Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Dec' 23	Sep' 23	Jun' 23	Mar' 23	Dec' 22

Sales

520.02

540.29

475.32

563.56

386.51

Operating profit

65.66

43.27

55.56

119.44

45.61

Interest

44.47

40.07

36.63

42.90

35.10

Gross profit

29.87

25.54

30.59

102.91

40.25

EPS (Rs)

0.28

0.14

0.89

6.91

1.39

Other income

8.69

22.34

11.65

26.38

29.75

Stock adjustment

-36.59

-2.43

9.55

46.76

-26.02

Raw material

302.14

288.94

215.10

203.55

237.57

Power and fuel

-

-

-

-

-

Employee expenses

85.66

86.25

76.70

64.53

64.95

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

103.15

124.27

118.40

129.29

64.41

Provisions made

-

-

-

-

-

Depreciation

21.06

21.34

21.46

22.71

22.26

Taxation

0.98

2.91

1.13

2.80

5.46

Net profit / loss

2.54

1.28

8.00

62.40

12.54

Extra ordinary item

-5.29

-

-

-15.00

-

Prior year adjustments

-

-

-

-

-

Equity capital

91.88

90.30

90.30

90.30

90.30

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

12.63

8.01

11.69

21.19

11.80

GPM (%)

5.65

4.54

6.28

17.44

9.67

NPM (%)

0.48

0.23

1.64

10.58

3.01